What Have We Learned about the Treatment of Idiopathic Membranous Nephropathy with Steroids?
- 26 January 1989
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 320 (4) , 248-250
- https://doi.org/10.1056/nejm198901263200411
Abstract
Idiopathic membranous nephropathy, one of the many renal diseases to emerge as a clearly defined clinicopathological entity after the use of renal biopsy became widespread, is characterized by distinctive changes in the glomerular capillary wall, which thicken the basement membrane yet increase its permeability to protein.1 , 2 In most patients, these changes lead to the development of the nephrotic syndrome at some time during the course of the disease. Typically, the course is chronic and slowly progressive, but it is variable, and ultimately a spontaneous complete remission occurs in about a quarter of untreated cases and renal failure in an approximately . . .Keywords
This publication has 10 references indexed in Scilit:
- A Randomized Controlled Trial of Prednisone in Patients with Idiopathic Membranous NephropathyNew England Journal of Medicine, 1989
- Through Thick and ThinNew England Journal of Medicine, 1989
- A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1989
- Idiopathic membranous nephropathy: The natural history of untreated patientsKidney International, 1988
- Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous NephropathyNew England Journal of Medicine, 1984
- Steroids to Prevent UremiaNew England Journal of Medicine, 1979
- A Controlled Study of Short-Term Prednisone Treatment in Adults with Membranous NephropathyNew England Journal of Medicine, 1979
- Treatment of Idiopathic Membranous NephropathyNew England Journal of Medicine, 1976
- Controlled Trial of Azathioprine and Prednisone in Chronic Renal DiseaseBMJ, 1971
- Controlled Trial of Prednisone in Adult Patients with the Nephrotic SyndromeBMJ, 1970